Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Motif A Step Closer To Succeeding With Iclaprim After Phase III Success

Apr 18 2017

• By Joseph Haas

Antibiotic resistant bacteria closeup biofilm

Related Content

Keeping Track: FDA Clears Big Batch Of Products; 'Breakthrough' For Bristol HIV Drug

Jul 27 2015

Pulling iclaprim out of the ashes

Jun 09 2015

US panel knocks efficacy of Arpida's iclaprim for skin infections

Nov 21 2008

Related Companies

Motif Bio plc

Roche Holding AG

Additional Topics

Business Strategies Clinical Trials Commercial Drug Approval Standards Drug Safety Research & Development Infectious Diseases BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.